A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)
Clinical trial NCT00687440 · COMPLETED
Trial details
- NCT number
- NCT00687440
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-15
- Primary completion
- 2008-10-24
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.